Exelixis (NASDAQ: EXEL) reported Q2 EPS of $0.91, $0.07 better than the analyst estimate of $0.84. Revenue for the quarter came in at $628.69 million versus the consensus estimate of $633.8 million.

GUIDANCE:

Exelixis sees FY2026 revenue of $2.5-2.55 billion, versus the consensus of $2.6 billion.

For earnings history and earnings-related data on Exelixis (EXEL) click here.